health

A UCLA-led research team has identified a drug and dose regimen that may cut the time by as much as 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.

New UCLA research finds that mental sharpness in women begins to decline as early as their 50s.

Researchers have demonstrated how specialized proteins are able to change the cellular characteristics of skin cells and create induced pluripotent stem cells, which have the ability to turn into any cell type in the body. The findings could influence the creation of healthy tissues to cure disease.

UCLA Jonsson Comprehensive Cancer Center researchers discuss the parallels — and the sometimes unexpected intersections between the two pursuits.

Blood donors representing many ethnicities and backgrounds pool precious resource to save woman’s life.

The device, developed by UCLA’s Aydogan Ozcan and colleagues in Sweden, could be manufactured for less than $500 each — far less expensive than the equipment that labs use for the same tests.

Dr. Edward Garon, UCLA Jonsson Comprehensive Cancer Center member and associate professor of hematology and oncology at the David Geffen School of Medicine, has received a new grant from the National Institutes of Health.

To turn on its genome — the full set of genes inherited from each parent — a mammalian embryo needs to relocate a group of proteins, researchers have discovered. The metabolic proteins move to the DNA-containing nuclei about two days after a mouse embryo is fertilized, according to the study.

California State Senate will discuss barriers, such as difficult-to-navigate health system, inadequate insurance, and cultural misconceptions, as well as possible solutions Jan. 12.

UCLA researchers have identified a signature brain-wave pattern for children with autism spectrum disorder related to a genetic condition. They say this signature is among the first quantitative biomarkers for any syndrome associated with autism spectrum disorder.

UCLA and the Los Angeles LGBT Center have developed a risk calculator that could help men who have sex with men decide whether to take pre-exposure prophylaxis.

UCLA-led researchers suggest that blocking a protein called type I interferon may actually help combat the virus that causes AIDS.

Researchers believe that modulating electrical signals in the autonomic nervous system holds promise for better ways to treat heart failure and other common cardiovascular problems.

UCLA-led research found people with advanced head and neck squamous cell carcinoma and a certain genetic mutation have improved survival when given a drug in combination with standard therapies.

Jonathan Fielding writes that universal adoption of flouridated water and bolstering the number of dentists accepting Medicaid could help counter the inequality.

Misuse of prescription and illicit drugs is so prevalent in Tijuana and East Los Angeles that community clinics in those areas should routinely, though discreetly, screen for it.

Amidst uncertain changes to federal health care policy, Gerald Kominski explores the future for California’s successful health care exchange and Medi-Cal programs.

The discovery could have important implications for treating white matter strokes, a major cause of dementia that also accelerate Alzheimer’s disease.

There are ways to both enjoy the holidays and keep healthy at the same time, says Erin Morse, chief clinical dietitian at the Ronald Reagan UCLA Medical Center.

The team found a way to correct the instability by resetting the stem cells from a later stage of development to an earlier stage. These results could have great impact on the creation of healthy tissues to cure disease.

Nearly half of 125 pregnancies studied resulted in defects among newborns or ended in fetal death.

A simple and inexpensive attachment could help to expand testing to regions with limited resources.

The findings could help improve upon standard behavioral therapy, in which people are exposed to the objects they’re afraid of — which can be frightening enough that some cannot complete treatment.

UCLA researchers have found that Tianshengyuan-1 increased activity of an enzyme that plays a role in regulating cell division, which is a factor in treating blood cell deficiency and cancer.

The California Health Interview Survey data show the rate of uninsured Californians fell to a new low in 2015, and fewer Californians cited cost as a reason to skip needed medical care.